中国组织工程研究

• 器官移植学术探讨 academic discussion of organ transplantation • 上一篇    下一篇

肾移植后不同免疫抑制剂抗排斥反应的临床应用及不良反应

肖海静   

  1. 武汉市中心医院,湖北省武汉市  430014
  • 收稿日期:2012-02-11 修回日期:2012-03-31 出版日期:2012-04-29 发布日期:2012-04-29
  • 作者简介:肖海静,女,1971年生,湖北省武汉市人,汉族,1998年湖北医科大学毕业,主要从事普内科疾病的研究。vcampus_doctor@163.com

Clinical anti-rejection effects and adverse reactions of different immunosuppressants after kidney transplantation  

Xiao Hai-jing   

  1. Central Hospital of Wuhan, Wuhan  430014, Hubei Province, China
  • Received:2012-02-11 Revised:2012-03-31 Online:2012-04-29 Published:2012-04-29
  • About author:Xiao Hai-jing, Central Hospital of Wuhan, Wuhan 430014, Hubei Province, China vcampus_doctor@163.com

摘要:

背景:如何利用免疫抑制剂之间的协同作用,发挥最佳疗效是肾移植后抗排斥反应的关键所在,如何做到个体化用药,提高疗效避免不良反应的发生显得尤为重要。
目的:评价不同免疫抑制剂对肾移植受者和移植肾存活的影响,以便更好地避免药物不良反应。
方法:应用计算机检索1999-01/2009-10 CNKI数据库相关文献,检索词为“免疫抑制剂,肾移植,排斥反应”。选择文章内容与肾移植免疫抑制剂有关者,同一领域文献则选择近期发表或发表在权威杂志文章,入选25篇文献进行综述。
结果与结论:任何一种免疫抑制剂在发挥免疫抑制作用时都会伴有一定毒副作用,临床上应尽量避免不良反应发生。联合用药抗排斥反应已达成共识,事实证明无论采用何种联合方式,均有单一用药无可替代的优势。如何利用免疫抑制药之间的协同作用,发挥最佳疗效是临床关键所在,医生应严密监测患者血药浓度,做到个体化用药,尽可能降低肾移植后排斥反应发生率。
关键词:免疫抑制剂;肾移植;排斥反应;环孢素A;吗替麦考酚酯;他克莫司
doi:10.3969/j.issn.1673-8225.2012.18.032
 

关键词: 免疫抑制剂, 肾移植, 排斥反应, 环孢素A, 吗替麦考酚酯, 他克莫司

Abstract:

BACKGROUND: The key of the anti-rejection after kidney transplantation is how to use the synergies between different immunosuppressants in order to get the optimal efficacy. But, how to do the personalized medicine, improve the efficacy and avoid the adverse reactions occurrence is particularly important.
OBJECTIVE: To investigate the effect of different immunosuppressants on kidney transplant recipients and graft kidney survival, in order to avoid the adverse reactions.
METHODS: A computer-base search was performed on CNKI database from January 1999 to October 2009 for the relate articles with the key words of “immunosuppressant, kidney transplantation, rejection”. The articles relate to the immunosuppressant after kidney transplant were selected, and for the articles in the same fields, those published recently or in the authorized journals were selected. Finally, a total of 25 articles were included to review.
RESULTS AND CONCLUSION: Any kind of immunosuppressant has certain side effects when they play an immunosuppressive effect, so we should try to avoid the occurrence of the adverse reactions in clinic. The principle of combination therapy is the consensus in anti-rejection after kidney transplantation. It proves that no matter what combination approach we use, we can get the irreplaceable advantages that single medicine can not get. How to use the synergies between different immunosuppressants in order to get the optimal efficacy is the key in chinic. So doctors should closely monitor the blood concentration of the patients and insist on personalized medicine, in order to minimize the rejection rates after kidney transplantation.

中图分类号: